Antiretroviral dose reduction: good for patients and rollout

Research output: Contribution to journalJournal articleResearchpeer-review

Standard

Antiretroviral dose reduction : good for patients and rollout. / Lundgren, Jens D; Phillips, Andrew.

In: Lancet, Vol. 383, No. 9927, 26.04.2014, p. 1442-1443.

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

Lundgren, JD & Phillips, A 2014, 'Antiretroviral dose reduction: good for patients and rollout', Lancet, vol. 383, no. 9927, pp. 1442-1443. https://doi.org/10.1016/S0140-6736(13)62556-8

APA

Lundgren, J. D., & Phillips, A. (2014). Antiretroviral dose reduction: good for patients and rollout. Lancet, 383(9927), 1442-1443. https://doi.org/10.1016/S0140-6736(13)62556-8

Vancouver

Lundgren JD, Phillips A. Antiretroviral dose reduction: good for patients and rollout. Lancet. 2014 Apr 26;383(9927):1442-1443. https://doi.org/10.1016/S0140-6736(13)62556-8

Author

Lundgren, Jens D ; Phillips, Andrew. / Antiretroviral dose reduction : good for patients and rollout. In: Lancet. 2014 ; Vol. 383, No. 9927. pp. 1442-1443.

Bibtex

@article{f78be8edb7f14e1ba415d9f2375e9821,
title = "Antiretroviral dose reduction: good for patients and rollout",
keywords = "Anti-HIV Agents, Benzoxazines, Female, HIV Infections, Humans, Male, Reverse Transcriptase Inhibitors",
author = "Lundgren, {Jens D} and Andrew Phillips",
year = "2014",
month = apr,
day = "26",
doi = "10.1016/S0140-6736(13)62556-8",
language = "English",
volume = "383",
pages = "1442--1443",
journal = "The Lancet",
issn = "0140-6736",
publisher = "TheLancet Publishing Group",
number = "9927",

}

RIS

TY - JOUR

T1 - Antiretroviral dose reduction

T2 - good for patients and rollout

AU - Lundgren, Jens D

AU - Phillips, Andrew

PY - 2014/4/26

Y1 - 2014/4/26

KW - Anti-HIV Agents

KW - Benzoxazines

KW - Female

KW - HIV Infections

KW - Humans

KW - Male

KW - Reverse Transcriptase Inhibitors

U2 - 10.1016/S0140-6736(13)62556-8

DO - 10.1016/S0140-6736(13)62556-8

M3 - Journal article

C2 - 24522177

VL - 383

SP - 1442

EP - 1443

JO - The Lancet

JF - The Lancet

SN - 0140-6736

IS - 9927

ER -

ID: 137312630